As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk
美国制裁瞄准manbetx3.0 药企，创新药企业面临最大风险

Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists.
随着manbetx3.0 的医药公司列入美国实体清单，华盛顿阻止尖端技术进入manbetx3.0 的行动出现了新走向，自主研发药物的公司在以后会面临更大压力。